In summary, we proposed that 4-week rimonabant treatment has a moderate effect on liver lipid metabolism in the early stage of obesity of ApoE*3Leiden.CETP mice under current experimental conditions. Here, APOE is linked to obesity due to melanocortin 4 receptor deficiency.